The Potential of Long-Reads to Uncover New Therapeutic Targets

28 Jan 2026
Main Stage
  • Testing compounds for patentable drugs 

  • Application of long-reads in splicing variation, organoids and iPSC models to reveal disease mechanisms 

  • Showcasing long-reads as a transformative tool for drug discovery 

Speakers
Wilfried Haerty
Wilfried Haerty, Group Leader - Earlham Institute